Advocacy
Beginning September 10, 2024, all mammography centers across the U.S. will be required to notify women about their breast density after having a mammogram. Studies reveal that many people are unaware that having dense breasts can increase their risk of breast cancer and most are unaware of what to do if they are told they […]
2024 State Legislative Sessions Mid-Year Review 34 – Number of states with Komen-led Legislation41 – Number of issues introduced in 2024 state sessions31 – Number of states where Komen engaged in coalition efforts24 – Number of states with enacted Diagnostic & Supplemental Imaging legislation11 – Number of states with enacted Komen-led legislation The Center for […]
Diagnostic and supplemental breast imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer. Not all insurance plans cover the out-of-pocket costs for this imaging, and the cost to patients can range from hundreds […]
Susan G. Komen thanks the Biden Administration for finalizing a rule that protects consumers from short-term health plans that are exempt from many consumer protections.
Komen Center for Public Policy is working to pass legislation that would prohibit copay accumulator adjustor programs and copay maximizers – two deceptive insurance practices that hurt patients and increase treatment costs.
Oral arguments were held in Braidwood Management, Inc. et al. v. Xavier Becerra et al., and the outcome of the case could prevent millions of Americans from accessing breast cancer screening and services.
Medicare now covers the cost of custom-fitting lymphedema compression garments for cancer patients. These garments improve health and quality of life for breast cancer patients, in particular, but out-of-pocket costs can make them unaffordable.
Susan G. Komen supports the nomination of Dr. Monica Bertagnolli to be the next director of the National Institutes of Health and thanks the Senate HELP Committee for its planned action to hold a confirmation hearing.
At the beginning of the COVID-19 pandemic, the U.S. Congress passed legislation requiring state Medicaid programs to keep people enrolled through the end of the public health emergency (PHE). This requirement ended in the spring, and many states started the process of unenrolling individuals over the late spring and early summer. Unfortunately, as of late […]
The Metastatic Breast Cancer (MBC) Access to Care Act, H.R.549/S.663, was reintroduced in the 118th Congress earlier this year by Reps. Andrew Garbarino (R-NY-02) and Kathy Castor (D-FL-14), along with Sens. Chris Murphy (D-CT) and Joni Ernst (R-IA).
Disparities in breast cancer outcomes are unacceptable and will only improve with sustained, collective action. That’s why Susan G. Komen’s Center for Public Policy proudly supports the recently introduced NIH Clinical Trial Diversity Act.
Ruth Travis was diagnosed with stage 0 breast cancer just two days before she turned 62. She’s now dedicated to helping other breast cancer survivors and patients. “I’ve got to do everything I can,” she said.
